Search

Angiotensin II (Ang II) induces the phenotypic modulation and hypertrophy of vascular smooth muscle cells (VSMCs), which is implicated in the pathogenesis of hypertension and atherosclerosis. Here we established a novel role of histone deacetylases 5 (HDAC5) in Ang II-induced VSMC hypertrophy. We showed that Ang II rapidly stimulated phosphorylation of HDAC5 (p-HDAC5) on Ser259/498 sites in a time- and dose- dependent manner in rat aortic VSMCs. Ang II receptor 1 mediated p-HDAC5. Protein kinase C (PKC) inhibitors, GF109203X and Gö6983, inhibited p-HDAC5. Using pharmacological inhibitor, siRNA and adenovirus encoding kinase-negative mutant of protein kinase D (PKD) demonstrated that PKD was essential for p-HDAC5 by Ang II. Moreover, we showed that Ang II stimulated HDAC5 nuclear export, which was dependent on its phosphorylation via PKC/PKD pathway, because HDAC5 nuclear export was abolished by inhibiting PKC and PKD and by infection of adenovirus encoding HDAC5 S259/498A mutant. Furthermore, both PKD inhibition and HDAC5 S259/498A mutant blocked Ang II-induced myocyte enhancer factor 2 (MEF2) transcriptional activation. Importantly, Ang II promoted VSMC protein synthesis in PKD and HDAC5-dependent manner. Our findings reveal for the first time that PKD and HDAC5 play a key role in Ang II-induced VSMC hypertrophy, and suggest that PKD and HDAC5 may emerge as potential targets for cardiovascular diseases. [ABSTRACT FROM AUTHOR]

Vascular endothelial growth factor (VEGF) is essential for many angiogenic processes. Histone deacetylases (HDACs) have emerged as key transcriptional regulators. Here we showed that VEGF induced Protein kinase D (PKD)-dependent HDAC5 phosphorylation and nuclear export in endothelial cells. VEGF rapidly, stimulated HDAC5 phosphorylation (p-HDAC5) at Ser259/498 residues in a time- and dose-dependent manner in bovine aortic endothelial cells and human umbilical vein endothelial cells. VEGF-induced p-HDAC5 was mediated via VEGF receptor 2, phospholipase Cγ (PLCγ), protein kinase C (PKC) and PKD pathway. Specifically, PLCγ and PKCs inhibitors diminished p-HDAC5. Inhibiting PKD by siRNA and adenovirus encoding kinase-negative mutant blocked p-HDACS. Furthermore, VEGF stimulated nuclear export of HDAC5 in a phosphorylation-dependent manner, which leads to myocyte enhance factors-2 (MEF2) transcriptional activation. Active PKD stimulated HDAC5 nuclear export and MEF2 activation. In contrast, inhibiting PKD prevented VEGF-mediated HDAC5 nuclear export and MEF2 activation. Moreover, adenovirus encoding HDAC5 S258/498A mutant abolished VEGF-mediated HDAC5 nuclear export and MEF2 activation. Our findings reveal a novel role of PKD and HDAC5 in VEGF regulation of gene transcription and suggest that PKD and HDAC5 may emerge as potential therapeutic targets for pathological angiogenesis. [ABSTRACT FROM AUTHOR]